newsfilter
← Latest News
GlobeNewswire·

Icosavax Appoints Dr. John Shiver to Board of Directors

SEATTLE, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, today announced the appointmen